Jiangsu Synthgene Biotechnology Co., Ltd.
PrivateLast Round
Series B
Nov 10, 2021
Total Funding Raised
$174.7M
Company Overview
Jiangsu Synthgene Biotechnology Co., Ltd. is a biotechnology company that provides upstream raw materials and solutions for life sciences, including mRNA, oligonucleotide, and cell and gene therapy manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Advanced Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Synthgene Biotechnology Co., Ltd. Comparables
Compare Jiangsu Synthgene Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yeasen Biotechnology (Shanghai) Co., Ltd. | 54% | |
| Hongene Biotechnology | 52% | |
| Novoprotein Scientific Inc. | 49% | |
Jiangsu Synthgene Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 10, 2021 | ||||
| Series A Extension | Dec 1, 2020 | ||||
| Series A Extension | Nov 11, 2020 | ||||
| Series A | Sep 6, 2020 | ||||
| VC Round | Jun 20, 2019 | ||||
Angel | May 22, 2018 |
Key People
Founding team and executive leadership
Jiangsu Synthgene Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series B |
| MSA Capital | Series B |
| ARCH Venture Partners | Series B, Series A |
| Frees Fund | VC Round, Angel |
| Chenling Capital | Series B, Series A Extension |
| Lilly Asia Ventures | Series B, Series A Extension, Series A |
| Superstring Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2021
$100M round led by Lake Bleu Capital.
- Sep 6, 2020
$30M round led by Lilly Asia Ventures.
Jiangsu Synthgene Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jiangsu Synthgene Biotechnology Co., Ltd.'s valuation, stock price, and market status.